Package 59651-214-30

Brand: azelastine hydrochloride

Generic: azelastine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59651-214-30
Digits Only 5965121430
Product NDC 59651-214
Description

1 BOTTLE, SPRAY in 1 CARTON (59651-214-30) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY

Marketing

Marketing Status
Marketed Since 2020-05-08
Brand azelastine hydrochloride
Generic azelastine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "c3f16181-99f1-406c-b795-d33ff0da7ef6", "openfda": {"unii": ["0L591QR10I"], "rxcui": ["1797867"], "spl_set_id": ["97c91a09-98d0-4666-8448-0bd50c02bb14"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (59651-214-30)  / 200 SPRAY, METERED in 1 BOTTLE, SPRAY", "package_ndc": "59651-214-30", "marketing_start_date": "20200508"}], "brand_name": "AZELASTINE HYDROCHLORIDE", "product_id": "59651-214_c3f16181-99f1-406c-b795-d33ff0da7ef6", "dosage_form": "SPRAY, METERED", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "59651-214", "generic_name": "AZELASTINE HYDROCHLORIDE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZELASTINE HYDROCHLORIDE", "active_ingredients": [{"name": "AZELASTINE HYDROCHLORIDE", "strength": "137 ug/1"}], "application_number": "ANDA212289", "marketing_category": "ANDA", "marketing_start_date": "20200508", "listing_expiration_date": "20261231"}